Montgomery County Public Health District announced the arrival of the federal Test-to-Treat program intended to treat patients testing positive for COVID-19 on April 5.
President Joe Biden’s administration launched the program March 8 to allow for the distribution of oral antiviral pills, such as Paxlovid—developed by Pfizer—and Molnupiravir—developed by Merck. Paxlovid received a U.S. Food and Drug Administration emergency use authorization, or EUA, on Dec. 22, while Molnupiravir received its EUA on Dec. 23.
Test-to-Treat centers allow patients who bring a positive COVID-19 test to a qualifying center to receive an evaluation and a filled prescription if necessary. According to the MCPHD, home test results can also be brought in for an evaluation at a Test to Treat center.
The county’s office of emergency management, or OEM, closed its COVID-19 hotline March 31, and calls relating to COVID-19 will be taken by MCPH, according to an OEM announcement.
According to the federal government’s locator, five Test-to-Treat centers are located within Montgomery County, mapped below:
For Montgomery County COVID-19 cases or questions, call the MCPHD at 936-523-5027.
A call center is also available for the Test-to-Treat program at 800-232-0233 (TTY 888-720-7489) to get help in English, Spanish and more than 150 other languages—8 a.m.-midnight EST daily.
The Disability Information and Access Line is also available to specifically help people with disabilities access services. To get help, call 888-677-1199 Monday-Friday from 9 a.m.-8 p.m. EST or email [email protected].
